Ignite Creation Date:
2024-05-06 @ 8:54 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02858791
Status:
COMPLETED
Last Update Posted:
2018-01-09
First Post:
2016-06-14
Brief Title:
MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension
Sponsor:
Northwell Health
Organization:
Northwell Health
Study Overview
Official Title:
MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators will investigate the interrelationship of macrophage migration inhibitory factor MIF and free T4 in patients with PAH
Detailed Description:
The investigators will test our hypothesis and accomplish our objectives by pursuing three Specific Aims
To investigate the interrelationship between macrophage migration inhibitory factor MIF and free T4 in patients with PAH with a working hypothesis that an increased release of MIF into the pulmonary vasculature during cardiopulmonary exercise changes the normal balance between plasma MIF and T4
To investigate the interrelationship between macrophage migration inhibitory factor MIF and free T4 in patients with PAH with a working hypothesis that an increased release of MIF into the pulmonary vasculature during cardiopulmonary exercise changes the normal balance between plasma MIF and T4
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None